《大行報告》瑞銀上調青啤(00168.HK)目標價至92.5元 評級「買入」
瑞銀發表研究報告指,鑑於青啤(00168.HK)的區域利潤優化、產品組合升級,以及原材料成本壓力緩解,今年首季業績強勁,明確的高端化戰略強化了該行對集團盈利增長前景的積極看法。管理層指引,今年每單位的銷售成本增長約1%,低於該行早前預期。該行將集團2023至24年的盈利預測上調25及21%,以反映勝於預期的利潤率改善。
該行認為,集團目前的估值具有吸引力,預計其H股相對A股的估值折讓將從目前的36%收縮,因為第二大股東復星國際(00656.HK)的減持計劃已於2022年6月結束,而管理層正與全球投資者改善溝通。該行將集團目標價由84.7元上調至92.5元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.